Less Is More in Lung Cancer Risk Prediction Models

In an invited commentary for JAMA Network Open, Marjolein Heuvelmans, MD, PhD, together with prof. Oudkerk, commented on current developments in the field of lung cancer screening risk prediction modelling. Specifically elaborating on the difference in lung cancer probability between baseline and newly detected nodules and the consequences this has for risk prediction modelling. To read the full article, head to: https://jamanetwork.com